EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 104 filers reported holding EPIZYME INC in Q1 2015. The put-call ratio across all filers is 0.96 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $125,000 | -34.6% | 10,330 | -46.8% | 0.03% | -28.3% |
| Q3 2016 | $191,000 | -86.6% | 19,413 | -86.1% | 0.05% | -82.5% |
| Q2 2016 | $1,428,000 | -15.2% | 139,448 | +0.4% | 0.26% | +8.2% |
| Q1 2016 | $1,683,000 | +40.6% | 138,889 | +85.9% | 0.24% | +88.4% |
| Q4 2015 | $1,197,000 | +346.6% | 74,700 | +424.3% | 0.13% | +396.2% |
| Q1 2015 | $268,000 | -57.1% | 14,247 | -57.0% | 0.03% | -56.7% |
| Q4 2014 | $625,000 | +47.8% | 33,108 | +112.2% | 0.06% | +62.2% |
| Q3 2014 | $423,000 | +31.0% | 15,605 | +9.9% | 0.04% | +76.2% |
| Q1 2014 | $323,000 | -19.2% | 14,195 | +42.1% | 0.02% | +16.7% |
| Q3 2013 | $400,000 | – | 9,991 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |